Lugon J R, Boim M A, Ramos O L, Ajzen H, Schor N
Department of Medicine, Escola Paulista de Medicina, Sao Paulo, Brazil.
Kidney Int. 1989 Oct;36(4):570-5. doi: 10.1038/ki.1989.232.
The renal effects of a single intravenous dose of two different E. coli lipopolysaccharides (LPS 0111:B4 and LPS 0127:B8), at the same dose of 100 micrograms/kg, were evaluated in euvolemic Munich-Wistar (MW) rats by whole kidney clearance techniques and micropuncture studies. Following LPS infusion, a significant decrease (8%) in mean BP was observed only in the LPS 0127:B8 treated group. Inulin clearance fell 57% (LPS 0111:B4), P less than 0.01, and 38% (LPS 0127:B8), P less than 0.01. Para-aminohippuric (PAH) clearance decreased 31% (P less than 0.01) and total effective renal vascular resistance rose 70% (P less than 0.03) in response to LPS 0111:B4. No significant change in PAH clearance was noted in the LPS 0127:B8 group. Superficial single nephron glomerular filtration rate (SNGFR) was reduced 69% (LPS 0111:B4), P less than 0.03, and 33% (LPS 0127:B8), P less than 0.02. Superficial glomerular plasma flow fell 48% (LPS 0111:B4), P less than 0.03, and 24% (LPS 0127:B8), P less than 0.03. Both lipopolysaccharides were associated with an increase in afferent arteriolar resistance (RA) which accounted for a reduction in the glomerular capillary hydraulic pressure (PGC). There was no change in the proximal tubular pressure in either group and, therefore, the net transcapillary hydraulic pressures were reduced. No measurable change in the ultrafiltration coefficient. Kf, was observed in either group. In a second set of protocols, the effect of prior administration of indomethacin or captopril on LPS 0111:B4 action was investigated. A significant decrease in BP occurred when animals were pretreated with captopril. Both indomethacin and captopril prevented the renal effects of LPS 0111:B4.(ABSTRACT TRUNCATED AT 250 WORDS)
采用全肾清除技术和微穿刺研究方法,在血容量正常的慕尼黑-维斯特大鼠(MW大鼠)中评估了单次静脉注射两种不同剂量(均为100微克/千克)的大肠杆菌脂多糖(LPS 0111:B4和LPS 0127:B8)对肾脏的影响。注射LPS后,仅在LPS 0127:B8治疗组中观察到平均血压显著下降(8%)。菊粉清除率在LPS 0111:B4组下降了57%(P<0.01),在LPS 0127:B8组下降了38%(P<0.01)。对LPS 0111:B4的反应,对氨基马尿酸(PAH)清除率下降31%(P<0.01),总有效肾血管阻力上升70%(P<0.03)。LPS 0127:B8组的PAH清除率无显著变化。浅表单肾单位肾小球滤过率(SNGFR)在LPS 0111:B4组降低了69%(P<0.03),在LPS 0127:B8组降低了33%(P<0.02)。浅表肾小球血浆流量在LPS 0111:B4组下降了48%(P<0.03),在LPS 0127:B8组下降了24%(P<0.03)。两种脂多糖均与入球小动脉阻力(RA)增加有关,这导致肾小球毛细血管液压(PGC)降低。两组近端小管压力均无变化,因此跨毛细血管净液压降低。两组的超滤系数Kf均未观察到可测量的变化。在第二组实验方案中,研究了预先给予吲哚美辛或卡托普利对LPS 0111:B4作用的影响。用卡托普利预处理动物时,血压显著下降。吲哚美辛和卡托普利均能预防LPS 0111:B4对肾脏的影响。(摘要截短于250字)